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ABSTRACT
Pain is a complicated phenomenon; it is an individual’s subjective experience and is often
characterized by its duration. Chronic pain lasts longer than 90 days and can continue after the
injury or illness that caused it has healed or gone away, Chronic pain was identified as a national
public health problem in a 2017 study by the National Academy of Medicine. Not only is chronic
pain a national problem, but there is an opioid epidemic in the United States that is perpetuated by
prescription pain medications. The opioid epidemic continues to consume veterans daily, but not
much is said about the providers who prescribe opioids to veterans. The uniqueness of veterans’
experiences while serving on active duty predisposes them to chronic pain treatable with opioids.
There are strategies to mitigate opioid overprescribing practices. The purpose of this paper is to
determine if the strategies implemented by the Veterans Health Administration are effective in
mitigating the risk of opioid overdose and death in veterans. This integrative review established
that the OSI initiative has been effective in improving the opioid prescribing practices of
providers because of the real-time data seen on the OSI dashboard causing a decrease in opioid
overdose and death; however, challenges exist, as all providers are not using the PDMP, and some
do not follow the steps of the OSI. With these challenges, there will continue to be opioid
overdoses and overdose death of the veteran.
Keywords: opioid safety initiative, prescription drug monitoring program, non-VA
provider, opioid overdose
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Opioids are commonly prescribed for pain. An estimated 20% of patients
presenting to physician offices with noncancer pain symptoms or pain-related diagnoses
(including acute and chronic pain) receive an opioid prescription (Centers for Disease Control and
Prevention [CDC], 2020; Daubresse et al., 2013). However, opioid pain medication use presents
serious risks, including overdose and opioid use disorder, while having the short-term effect of
treating chronic pain (Boudreau et al., 2009)
Pain management is a medical specialty and has evolved with advances in medications
and therapeutic procedures. A complete and combined pain management approach requires both
medical and psychological treatment (VA Office of Inspector General [OIG], 2018). Considering
veterans’ unique experiences, it is not surprising that so many veterans suffer from some form of
chronic pain. In 2013, the Deputy Under Secretary for Health informed Congress that more than
50% of veterans who obtained care through the Department of Veterans Affairs (VA) were
affected by chronic pain (VA OIG, 2017).
Throughout the 1990s and into the 21st century, the US has seen a surge of
substance abuse disorders, primarily driven by prescription opioids. As a result, from 1999 to
2019, more than 500,000 people died from a drug overdose, in a twenty-year period prior to 2019
there were six times the number of opioid-involved overdose deaths (CDC, 2020). The overall
harmful effects of this crisis have been diverse. For example, in 2019, in five percent of U.S.
counties, enough opioid prescriptions were dispensed for every person to have one, while the
overall dispensing rate of prescriptions was 46.7 prescriptions per 100 people (CDC, 2020).
The opioid epidemic has impacted veterans. Overdose and overdose deaths among
veterans remain elevated compared to the civilian population (Bohnert et al., 2011). Because of
the number of veterans seen at the VA and the limited number of providers, veterans are often
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referred to contracted non-VA providers under the Mission Act, a purchased care program that
enables veterans to access medical care in the community when necessary (VA OIG, 2017).
In partnering with contracted non-VA providers, the VA has implemented safe opioid
prescribing practices to ensure that opioids are appropriately prescribed to veterans. A detailed
integrated review will permit this project leader to demonstrate that the Opioid Safety Initiative
(OSI) and the prescription drug monitoring program (PDMP) are dependable when appropriately
used. This integrated review will show that if non-VA providers followed the OSI steps when
prescribing opioids to veterans, veteran opioid overdose and death would be mitigated.
Background
Overdose deaths involving prescription opioids have quadrupled since 1999. In 2014,
more than 14,000 lives were lost to opioid overdoses involving prescription opioids (CDC, 2020).
With growing opioid overdose deaths, the emphasis on opioid prescribing has shifted to opioid
dose reduction, increased assessment, and monitoring of patients on chronic opioid therapy (VA
OIG, 2017).
Millions of Americans experience agonizing pain and are often prescribed opioids as
treatment. The dangers of opioid overprescribing, opioid use disorder, and opioid overdose have
been a growing problem throughout the United States (CDC, 2020). Overdose deaths involving
prescription opioid medications are comparable to poisoning deaths from other drugs and
accounted for 27% or 17,181 of 63,632 overall drug overdose deaths in 2016 (Moyo et al., 2017).
Prescription opioid overdose remains an essential issue despite the decreased number of opioid
prescriptions dispensed (Pezalla et al., 2017).
The opioid epidemic continues to consume veterans daily, but not much is said about the
provider’s prescribing practices that place opioids in veterans’ hands. The uniqueness of veterans’
experiences while serving predisposes them to chronic pain treatable with opioids. During pain
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management, the medical use opioid prescription often becomes a nonmedical use prescription
opioid (NMUPO). NMUPO is a national concern primarily driven by the high and rising NMUPO
in the veteran population. These drugs, which non-VA providers overprescribe, have the
propensity to cause respiratory depression or overdose or lead to dysrhythmias, hypertension,
heart failure, stroke, or seizures. In the US, the rate of opioid-involved overdose deaths between
2000 and 2014 increased by 200% (Rudd et al., 2016). The number of overdoses caused by
opioids seen in the emergency department increased by 30% between 2016 and 2017 (VivoloKantor et al., 2018). Additional care and safety measures must be put in place for high-risk
veterans treated by non-VA providers before they prescribe opioids.
A complete review is required to determine if the OSI and PDMP initiatives provide safe
and effective opioid prescribing practices for non-VA providers. This project lead will complete a
detailed integrated review to determine if non-VA providers’ accurate compliance with and
complete utility of the OSI and PDMP would decrease veteran opioid overdoses and death. Parts
of this initiative must be addressed to ensure the rigor of the response to this question. For the past
eight years, the OSI has been used to address the safety concerns of opioid prescribing practices
to high-risk patients. However, there remains an epidemic of gross proportion of NMUPO for
veterans.
Defining Concepts
•

Care coordination: The deliberate organization of patient care activities and sharing of
information among all participants concerned to achieve safe and effective care.

•

Chronic pain: Any pain that lasts three to six months or more. This pain can affect an
individual’s physical, emotional, and mental health.

•

Opioid Safety Initiative (OSI): The first of several VHA initiatives to address opioid
overuse. These initiatives reduced the use of opioid medications VA and non-VA
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providers, and improved the safety of opioid prescribing while expanding alternative pain
therapies.
•

Nonmedical use prescription opioid (NMUPO): The use of another person’s opioid
medication or use of the medication only for the experience it causes. NMUPO is
associated with the use of heroin and psychiatric, medical, and non-opioid substance use
problems.

•

Pain: An unpleasant sensation caused by actual or perceived injury to body tissues
producing a physical and emotional reaction.

•

Pain management: A specialty of training in evaluating, diagnosing, and treating all
different pain types.

•

Prescription drug monitoring program (PDMP): An electronic database that tracks
controlled substance prescriptions in states. PDMPs can provide health authorities timely
information about prescribing and patient behaviors that contribute to the opioid epidemic
and facilitate targeted response.

Rationale for Conducting the Review
The OIG has resolved that a significant risk exists for veterans who are in anguish from
chronic pain and mental health illnesses and obtain opioid prescriptions from non-VA providers
where opioid prescribing practices and monitoring guidelines conflict with VA guidelines (VA
OIG, 2017). Furthermore, the risk is intensified when information about the veteran’s opioid
prescriptions is not shared between VA and non-VA providers. Identified health information
sharing and care coordination between VA and non-VA providers are often nonexistent (VA OIG,
2017). Care coordination addresses the patient’s needs and preferences prior to care delivery and
communicated to the correct people at the right time. This information is conveyed to provide
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safe, appropriate, and effective care of the patient (Agency for Healthcare Research and Quality,
2018).
Purpose of the Project
The purpose of this integrative review is to identify and examine the literature related to
safety initiatives implemented by the Veterans Health Administration (VHA) that would mitigate
the risk of opioid overdose and death of veterans.
Review Questions
•

Does the noncompliance with the OSI by non-VA opioid prescribing providers have a
causal effect on veteran opioid overdose and death?

•

What is the effectiveness of the OSI and PDMP on the opioid prescribing practices of
non-VA providers who treat veterans?

Because the OSI is a national initiative, this review’s positive or negative outcome must be
disseminated to the VHA to support analysis. This project leader will review all articles included
in this integrated review for the effectiveness of the OSI and PDMP and how these initiatives
mitigate opioid overdose and death. Safety is primary when it concerns veterans and mitigating
the risk of an undesirable effect from prescription opioids.
Inclusion and Exclusion Criteria
According to Toronto and Remington (2020), “Because integrative reviews address broad
questions, it is likely that a search will retrieve large volumes of literature. Application of the
inclusion and exclusion criteria makes the amount of literature manageable” (p. 17). The project
leader conducted a comprehensive search of six databases: ProQuest, PubMed, Medline,
CINAHL, Psychology & Behavioral Sciences Collection, and Health Source: Nursing/Academic
Edition, along with manual sources. Keywords used were opioid prescribing practices, opioid
prescribing, opioids, long-term opioid therapy, veterans, Veterans Affairs, OSI, PDMP,
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community care provider, non-VA provider, and Mission Act. The Liberty University librarian
was also consulted to assist with the literature search.
Articles dated 2012 and later were considered because the OSI initiative was developed
and implemented after 2012, and the OSI is a significant part of this review. Studies were
considered if the sample population was made up of veterans and the study took place in a VA
medical center within the US. Age of the veteran was not a consideration for this review.
Interventions of concentration included the OSI and PDMP, which are used to enhance the VA
opioid safety efforts. Outcomes of interest were those explicitly related to safe opioid prescribing
practices and the OSI, including the PDMP. The number of articles excluded was 273. Studies
were excluded if the topic was not related to safe opioid prescribing practices (n = 109). Also
excluded were articles with limited quality research (101), studies that used a location outside of
the US (n = 32), studies with a level of evidence of five or more (on Melnyk’s level of evidence)
and articles that were missing an abstract (n = 31). The project leader identified 20 articles for
inclusion to address the safety measures needed when prescribing opioids to veterans. Melnyk’s
level of evidence was used to sort and support the article’s quality and strength (Melnyk, 2016).
The articles utilized included four Level I studies, four Level II studies, four Level III studies,
four Level IV studies, three Level V studies, and one Level VI study.
Conceptual Framework
A framework is a structure that provides support in organizing and shaping. It is much like
a house’s frame that supports its roof, walls, and structures. A conceptual framework is less
formal in organizing facts than a theoretical framework. A conceptual framework describes the
unified and central concepts of the issue or subject (Polit & Beck, 2014). The conceptual
framework of an integrative review is very complex and is developed using a standardized,
systematic method to ensure the required rigor of research and therefore establish the validity of
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evidence. The problem and purpose of this review are vital to this project and have clearly been
defined to provide limitations for the integrative review process (Whittemore & Knafl, 2005).
SECTION TWO: COMPREHENSIVE AND SYSTEMATIC SEARCH
The literature search utilizes diverse terms, databases, various search strategies, and
inclusion and exclusion criteria to determine relevant primary sources (Whittemore & Knafl,
2005). A comprehensive search was conducted using six databases: ProQuest, PubMed, Medline,
CINAHL, Psychology & Behavioral Sciences Collection, and Health Source: Nursing/Academic
Edition, along with manual sources. The manual sources were retrieved after the database search
was exhausted. Manual searching included, but was not limited to, searching references from
retrieved studies and assessing articles related to safe opioid prescribing practices. The search was
then revised according to each specific database to get the most relevant results. The search terms
were improved during an experimental search, and additional search terms were identified from
retrieved articles. Articles were published between 2012 and 2021. The Liberty University
librarian was also consulted to assist with the literature search.
Search Strategy
The project leader’s search revealed 333 articles from the search databases when the
words “safety practices” were added to the search. A total of 273 articles were excluded for the
following reasons: topic not related (n = 109), limited quality of article (n = 101), study location
was outside of a VA (n = 32), studies with a level of evidence of five or more, or article was
missing abstract (n = 31). Duplicates (n = 40) were then removed, leaving 20 peer-reviewed
journal articles for this integrative review. Keywords used were opioid prescribing practices,
opioid prescribing, opioids, long-term opioid therapy, veterans, Veterans Affairs, OSI, PDMP,
community care provider, non-Veterans Affairs provider, and Mission Act. An evidence
(literature) matrix (Appendix A) and the Preferred Reporting Items for Systematic Reviews and
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Meta-Analyses (PRISMA; Appendix B) were used to reveal all pertinent information regarding
the safe practices of prescribing opioids to veterans. These tools assisted in validating the
intervention that will mitigate unsafe practices and prevent opioid overdose and overdose death of
the veteran (Guo & Jacelon, 2014; Page & Moher, 2017).
It is common in research studies to identify the inclusion and exclusion criteria for an
integrative review. Inclusion and exclusion in research are a means of controlling research
variables to ensure that contributing groups are as much alike as possible. The project leader
excluded 313 articles and identified 20 articles for inclusion. Melnyk’s hierarchy of evidence
supports the article’s quality and strength (Melnyk et al., 2010). Four Level I articles, four Level
II articles, four Level III articles, three Level IV articles, three Level V articles, and one Level VI
article were included in this integrative review.
Terminology
Database terminology can be confusing, mainly because words have different meanings in
different professions. For this integrative review, the words platform, database, and software will
be used as described below:
•

A platform is an integrated technology solution that allows data located in database(s) to
be governed, accessed, and delivered to users, data applications, or other technologies for
strategic business purposes (Homewood, 2000).

•

A database is a collection of independent woks, data or other materials, arranged in a
systematic or methodical way and individually accessible by electronic means (Derclaye,
2002)

•

Software are the programs and other operating information used by a computer (Gagliardi,
1980).
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SECTION THREE: MANAGING COLLECTED DATA
Primary research on the project subject was complex because of the large number of
concepts related to prescription opioids studied over the years across multiple health care
disciplines. The project leader was the only individual collecting the literature and following the
steps of the data collection process. Before beginning the research project, the researcher
completed the Collaborative Institutional Training Initiative (CITI), and the project was approved
by Liberty University’s Institutional Review Board (IRB).
After a comprehensive literature search was conducted and results were refined using the
inclusion and exclusion criteria, the remaining articles were imported into Zotero. Zotero is a free
and open-source reference management software that manages bibliographic data and related
research materials. This software includes adding web browser information, online syncing, and
creating in-text citations, footnotes, and bibliographies ((Klemme Eliceiri, 2014). This software
was chosen as the tool to sort the articles chosen and make the process more efficient.
Screening, Selecting, and Sorting Data
Before the articles were entered into Zotero, they were screened. First, the project lead
assessed the titles and abstracts. This process was incorporated to remove studies not relevant to
the project. The second step to data collection was to retrieve and select full-text articles; the
articles should have met all the required criteria. However, at times, valuable articles may not
have had all the required criteria and still was utilized. The third part of data collection is the
process of sorting the articles into studies. Sometimes one report contains numerous studies that
should be treated separately (Toronto & Remington, 2020). PRISMA was used to screen and
select the data to be included (Page & Moher, 2017).
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SECTION FOUR: QUALITY APPRAISAL
This project undertakes the initiative to identify value in the standing literature regarding
opioid prescribing practices. This research focuses on what non-VA providers should or should
not do to deliver safe opioid prescriptions to veterans. The OSI which contains the PDMP are two
popular safety tools used to provide safe opioid prescribing practices. To determine if the OSI and
PDMP are suitable ways of ensuring safe opioid prescribing practices and decreasing opioid
overdose and overdose deaths is the purpose of this literature review.
The project lead reviewed all of the articles related to safe practices for prescribing opioids
to veterans and determined which ones met the requirements for inclusion and therefore lay the
foundation for a solid answer to the integrative review question. During the literature analysis, the
features of the reviewed studies were placed on a spreadsheet for analysis. The studies were
analyzed by design, method, research validity, and reliability. The studies were performed using a
variety of research and data collection methods. Many of the studies were retrospective (n = 7,
35%), Cohort (n=4, 20%) Qualitative (n=3, 15%) there were multiple study designs for the
remaining six articles. There was no significant design correlation between the remaining studies;
the quality assessment was performed to provide the author and future readers with an awareness
of the quality of the included studies without excluding studies of lower quality (Singh, 2013).
Sources of Bias and Validity
With today’s internet connectivity moving at tremendous speeds, it is not easy to remain at
the front of research and assess the shared evidence in a particular area of research. For this
reason, a literature review as a research process is more relevant than ever. Traditional literature
reviews often lack thoroughness and rigor and are conducted ad hoc rather than according to a
specific methodology. Therefore, questions can be raised about the quality and trustworthiness of
these types of reviews, as they are often biased sources (Snyder, 2019). The trustworthiness of the
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articles can be assessed by looking at four components: (a) transferability, or the ability to transfer
conceptual findings to other settings; (b) credibility, which means that the research account is
believable and appropriate; (c) dependability, the use of methods and decisions that are logically
traceable and documented; and (d) confirmability, which is the extent to which findings are
grounded in the data (Toronto & Remington, 2020).
A tool that was used to ensure the rigor of the findings and adequate reporting is the
PRISMA flow diagram (Page & Moher, 2017). The flow diagram served to reduce the bias that
could exist from a focus that is too narrow during the literature search. During this integrative
review, there was no risk of bias noted within the themes or strategies of the selected studies. No
risk of bias was relevant to the safe prescribing practices of opioids to veterans.
Internal Validity
The project leader’s search revealed 733 journal articles from the search databases. When
the words “safety practices” were added, the search revealed 333 journal articles; these articles
were further reviewed. Two hundred ten articles were excluded due to lack of relevance to the
project topic, differentiating weaknesses, limited quality of research, and limitations. Forty fulltext articles were excluded because of duplication, population, and cause of pain. Thirty-two
articles were excluded because the study location was outside of a VA Medical Center or
contracted facility. Thirty-one articles were excluded because the level of evidence was five or
greater, and the articles were missing either an abstract, design, or method.
Critical Appraisal Tools
Tools used to appraise studies for this integrative review include the literature matrix,
Zotero, PRISMA diagram, and Melnyk’s levels of evidence. All of the tools discussed have been
previously established.
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Evidence or literature matrix: Writings from one author cannot answer a research
question. However, the writings of many authors who are experts in the field and are
addressing the same issue can be compared. The matrix method is a structured, systematic
process for reviewing literature and bringing order out of the chaos of too much
information spread across too many sources (Goldman & Schmalz, 2004; Mathews,
2004).

•

Melnyk’s levels of evidence: The tool used to evaluate the research articles’ quality and
strength was Melnyk’s levels of evidence (Melnyk et al., 2010). A standard notation for
the relative weight of different primary studies used when making decisions about clinical
interventions also considers the “hierarchy of evidence,” which comprises the following
levels. Level I articles provide evidence from a systematic review or meta-analysis of all
relevant randomized controlled trials or evidence-based clinical practice guidelines based
on systematic reviews of randomized controlled trials. Level II study’s comprise evidence
obtained from at least one well-designed randomized controlled trial. Level III articles
provide evidence obtained from well-designed controlled trials without randomization.
Level IV articles include evidence from well-designed case-control or cohort studies.
Level V articles provide evidence from systematic reviews of descriptive and qualitative
studies. Level VI articles contain evidence from a single descriptive or qualitative study.
Level VII articles present evidence from the opinion of authorities and reports of expert
committees (Melnyk et al., 2010). Melnyk’s levels are denoted in the literature matrix of
this paper (see Appendix A).

•

PRISMA: This tool is used as a reporting guideline to provide evidence-based
recommendations for authors on how to report their research methods and findings clearly
(Guo & Jacelon, 2014; Page & Moher 2017).
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Zotero: Zotero is well-developed, free, online software with the capability to capture,
store, annotate, and cite web pages. This unique tool is of great value to anyone who
retrieves information from the internet. Zotero’s sorting, note-taking, and organizing
capabilities are intuitive and easy to use. Zotero also has the advantage of being free, open
source, and supported by an energetic community of users. Because of these features,
Zotero is beneficial to users of PubMed for quick capture of bibliographic data (Klemme
Eliceiri, 2014; Trinoskey et al., 2009).

Applicability of Results
This integrative review identified multiple studies on the subject of patient health
outcomes. However, seven studies included evidence of inappropriate prescribing practices
whereby documentation was related to self-reported outcomes such as pain control and quality of
life. Among the studies that evaluated patient health outcomes, the results were mixed, and
notably, tapering opioid analgesics did not always lead to improved patient outcomes. Although
patient health outcomes are essential for understanding the impact of prescribing limits, they are
difficult to measure.
The OSI had a major contributing impact on veteran overdose and overdose deaths; after
implementing the OSI initiative, opioid overdose and overdose deaths began to decline rapidly.
The OSI had an immediate effect on suicides for veterans, there was no location that was better or
worse than the other, and its effect increased each year for all veterans. It is suggested that the
evolution of the OSI initiative can explain decreased veteran overdoses and deaths. Over time, as
the OSI gained momentum in decreasing adverse opioid prescribing, it also played a large part in
making the PDMP use mandatory for all providers who prescribe opioids.
PDMPs were not meaningfully associated with decreased drug overdoses, opioid overdose
deaths, or lower rates of ingesting opioid drugs. PDMP states consumed more significant amounts
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of Schedule III and nonsignificant amounts of Schedule II opioids. The increases in overdose
mortality rates and use of prescription opioid drugs from 1999 to 2005 were significantly lower in
three PDMP states (California, New York, and Texas) that required the use of unique prescription
forms. While PDMPs are potentially an important tool to prevent the NMUPO, the impact is not
seen in drug overdose or overdose mortality rates.
Implementing the OSI dashboard made a vast difference in the effectiveness of the OSI as
it relates to provider opioid prescribing practices. From 2012 to 2019, the charted data forms a
bell curve. The number of prescriptions written by non-VA providers has drastically declined.
The use benzodiazepines concurrently with opioids is associated with an increased risk of death
from overdose, which has gone down significantly. The OSI Dashboard makes the totality of
opioid use visible within the VHA and provides feedback to stakeholders at VA facilities
regarding fundamental limitations of opioid prescribing and providers out of compliance.
The results of this integrative review signify that the OSI had a major effect on opioid
overdose and death. However, there is an OSI dashboard that lists all patient names and providers
contracted by the VA. Determining if the providers are compliant with the OSI can be
accomplished using the veteran’s electronic health record (EHR). Other review results signify that
there remain barriers to the utilization of the PDMP, reducing its effectiveness in increasing the
safe opioid prescribing practices of non-VA providers who treat veterans. Overall, the VHA has
an OSI that, if used correctly, has the potential to identify the veteran who is at risk for opioid
overdose and death.
SECTION FIVE: DATA ANALYSIS AND SYNTHESIS
During the literature analysis, the characteristics of the reviewed studies were placed on a
worksheet for analysis. The studies were analyzed based on their design, method, research
validity, and reliability. The studies had been conducted using a variety of research and data
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collection methods. Many of the studies were retrospective (n = 7, 35%), Cohort (n=4, 20%)
Qualitative (n=3, 15%) there were multiple study designs for the remaining six articles. There was
no significant design correlation between the remaining studies; the quality assessment was
performed to provide the authors and future readers with an awareness of the quality of the
included studies without excluding studies of lower quality (Singh, 2013).
Literature (Evidence) Matrix
Whittemore and Knafl (2005) used several methods to synthesize studies, including a
constant comparison method. The overall classification scheme was based upon the study purpose
and initially derived after analysis of study outcomes. Data analysis procedures consisted of five
concurrent activities: data reduction, data display, data comparison, conclusion drawing, and
verification (Miles & Huberman, 1994; Whittemore & Knafl, 2005).
Data reduction is the process of organizing masses of data and somehow meaningfully
reduced or reconfigure the data. The first step of data reduction is selecting. The selection process
began after determining what the project was going to be and the review questions. Articles from
the inclusion and exclusion process is as follows: The project leader’s search revealed 333 articles
from the search databases. Articles excluded were: (n=273) topic not related =109, Limited
quality of research articles =101, study location was outside of a VA=32, Level of evidence was
five or missing abstract = 31. Records after duplicates were removed (n=40), leaving 20 peerreviewed journal articles for this integrative review. Data was then extracted and placed in a
literature (data) matrix. The project leader reduced a large amount of data to that which was
significant and relevant to the safe prescribing of opioids to veterans. Concise organization of the
literature to appropriately compare the study ideas was achieved.
Data display is the process of displaying extracted data. Data can be displayed in the form
of a matrix, chart, graph, or network. For this project, the data are displayed in a literature (data)
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matrix. These displays enhance the visualization of patterns and relationships within and across
primary data sources and serve as a starting point for interpretation (Whittemore & Knafl, 2005).
For the sake of this study, the matrix used the following column headings: article title,
background, study, purpose, design, study results/findings, and level of evidence. The literature
review matrix organized the articles and allowed mastery of the literature (Garrard, 2017). The
matrix method is a structured process for reviewing literature and bringing order out of the chaos
of too much information spread across too many sources (Goldman & Schmalz, 2004; Mathews,
2004).
The next step in data analysis is data comparison, which involves examining data displays
to identify patterns, themes, or relationships. Once patterns begin to form, a distinguishable
conceptual map can be drawn (Brown, 1999). Similar variables are grouped, and a sequential
order can be displayed. Relationships can also be shown between variables or themes. This data
visualization and comparison process can clarify the practical and theoretical support emerging
from early explanatory efforts (Brown, 1999; Miles & Huberman, 1994).
Conclusion drawing and verification is the final phase of data analysis in which the
interpretive effort moves from describing patterns and relationships to describing higher levels of
the idea, synthesizing the particulars into the general. Conclusion drawing is when ideas,
conclusive thoughts, and deductive reasoning are integrated. The researcher determines what
trends and conclusions will be explored and what data sources will be used to support them. Bias
is any trend or deviation from the truth in data collection. Bias can occur either intentionally or
unintentionally. Intentionally presenting bias into someone’s research is immoral. However,
considering the possible implications of a biased research, it is irresponsible to conduct and
publish a biased research unintentionally (Smith & Nobel, 2014). The project leader took three
common themes through the synthesis process and developed a strategic awareness that will
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inform and improve opioid prescribing practices of non-VA providers. This awareness will be
disseminated to the VHA (Whittemore & Knafl, 2005).
Thematic Analysis
Thematic analysis is a common form of analysis of qualitative data. It involves the
identification, analysis, and reporting of patterns (or “themes”) within data (Braun & Clarke,
2006). This review seeks to answer the questions related to safe opioid prescribing practices of
non-VA providers who care for veterans. The following themes arose during the data analysis.
Inappropriate Prescribing Practices
Inappropriate prescribing practices include the prescription of high daily doses of opioids,
concurrent benzodiazepine administration, and geriatric-related indicators. Given the significant
contribution of inappropriate opioid prescribing to opioid-related harms, identification of these
practices is essential to update and improve opioid prescribing practices among health care
providers (Kim et al., 2019)
Opioid Overdose
Opioid overdose occurs when a person has excessive unopposed stimulation of the opiate
pathway. Opioid overdose can lead to decreased respiratory effort and possibly death. The
frequency of opioid overdose is rapidly increasing. Drug overdose is the leading cause of
accidental death in the United States, with opioids being the most common drug involved in
overdose (Schiller et al., 2021).
Opioid Safety
Opioids are a class of controlled drugs naturally found in opium poppy plants. Some
prescription opioids come from the plant directly, while scientists in labs make others. Opioids
contain chemicals that relax the body, and doctors prescribe them to assist patients with moderate
to severe pain. Opioids can be highly addictive, and overdoses or death can be expected results if
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not handled appropriately. Opioid safety necessitates using all tools necessary to provide safe
opioid prescribing (Moyo et al., 2017).
Synthesis
The final step of the data analysis in an integrative review is the synthesis of essential
elements or conclusions into an integrated summation of the topic or phenomenon. The first
element of the summation is to ensure that non-VA providers follow the criteria of the OSI, which
will prevent any undue harm to the veterans when prescribed opioids. The OSI SharePoint
provides data on providers who do not comply with the OSI standards and which standard was
not met. Once the Chief of Staff is informed of the potential harm the non-VA provider has
exposed the veteran to, the provider’s contract should be revoked. Until the provider is retrained
and their competency regarding the OSI has been satisfactorily proven, no further patients will be
sent to this provider.
Next, the OSI and PDMP are practical tools that should be used by providers that will
mitigate the risk of opioid overdose and death of the veteran if and only if the providers put them
to use. There is evidence that either the provider does not have the capacity electronically to
obtain the veteran’s PDMP, or they feel it is time consuming. There is positive evidence that the
OSI that includes the PDMP has decreased opioid overdose and deaths since its inception in 2013.
Ethical Considerations
The project was submitted to and approved by Liberty University’s IRB. A copy of the
IRB approval letter is provided in Appendix D. A copy of this DNP student’s CITI Certificate is
provided in Appendix C.
SECTION SIX: DISCUSSION
The purpose of this integrative review is to identify and evaluate the literature related to
safety initiatives implemented by the VHA that would mitigate the risk of opioid overdose and
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death of veterans. Opioids are commonly prescribed for pain. An estimated 20% of patients
presenting to physicians’ offices with noncancer pain symptoms or pain-related diagnoses
(including acute and chronic pain) receive an opioid prescription (CDC, 2020; Daubresse et al.,
2013). However, opioid pain medication use presents serious risks, including overdose and opioid
use disorder, while having the short-term effect of treating chronic pain (Boudreau et al., 2009).
Overdose deaths involving prescription opioids have quadrupled since 1999. In 2014,
more than 14,000 lives were lost to opioid overdoses involving prescription opioids (CDC, 2020).
With growing opioid overdose deaths, the emphasis on opioid prescribing has shifted to opioid
dose reduction, increased assessment, and monitoring of patients on chronic opioid therapy (VA
OIG, 2017).
The opioid epidemic continues to consume veterans daily, but not much is said about
providers’ prescribing practices that place opioids in veterans’ hands. The uniqueness of veterans’
experiences while serving predisposes them to chronic pain treatable with opioids. During pain
management, the medical use opioid prescription often becomes an NMUPO. NMUPOs are a
national concern primarily driven by the high and rising NMUPO in the veteran population. These
drugs, which non-VA providers overprescribe, have the propensity to cause respiratory depression
or overdose or lead to dysrhythmias, hypertension, heart failure, stroke, or seizures. In the US, the
rate of opioid-involved overdose deaths between 2000 and 2014 increased by 200% (Rudd et al.,
2016). The number of overdoses caused by opioids seen in the emergency department increased
by 30% between 2016 and 2017 (Vivolo-Kantor et al., 2018). Additional care and safety measures
must be implemented for high-risk veterans treated by non-VA providers before opioids are
prescribed.
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Review Questions:
1. Does the noncompliance with the OSI by non-VA opioid prescribing providers
contribute to veteran opioid overdose and death? 2. What is the effectiveness of the OSI and
PDMP on the opioid prescribing practices of non-VA providers who treat veterans?
Response to Review Questions: 1. The OSI reduces the risks associated with long-term opioid
therapy, including opioid use disorder, overdose, and death, when providers are compliant with
its’ use. When providers are non-compliant with the use of the OSI, this overshadows the primary
purpose of the OSI, which is to mitigate and contribute to opioid overdose and overdose death.
2. As previously stated, the OSI effectively reduces opioid overdose and deaths because it
diminishes unsafe prescribing practices of non-VA providers. PDMP proves to be an effective
tool to recognize when patients have been prescribed an opioid from more than one provider.
However, due to infrastructure barriers, non-VA providers do not use or do not have the PDMP
available. The result is Veterans with polypharmacy and or a high dosage of opioids. Moreover,
at-risk patients potentially will overdose or die from an opioid overdose. The OSI is a VHA
directive, and guidelines will be revisited to monitor gaps that must be sufficiently addressed to
warrant an update of the guideline and study recommendations for future updates when necessary.
Interpretation of Findings
Inappropriate Prescribing Practices
While prescription opioids can be effective for treating acute pain, inappropriate
prescribing practices can increase the risk of opioid-related problems, including overdose and
death (Kim et al., 2019). During fiscal year 2016, 13,928 patients were prescribed opioid
medications by choice or (community) providers or both choice and VA providers, and the
prescriptions were filled in VA pharmacies. Of these patients, 5,590 were prescribed opioid
medications only by choice providers. Since all prescriptions filled at VA pharmacies appear in
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the patient’s medical record, any provider within VA medical system would be able to view the
patient’s current medication to include opioid history, avoiding any repeat ordering of opioids.
While 13,928 may appear to be an insignificant number compared with the overall number of
veterans prescribed opioids within the VHA system (877,253), it is essential to note that the actual
number of opioid prescriptions dispensed to these 13,928 patients totaled 85,729 (VA OIG, 2017).
Within the population of patients treated through the VHA, increased rates of opioid
prescribing have been related to an increased rate of death from overdose; on an individual level,
the peril of death from overdose is higher among those receiving higher doses of opioids. Rose et
al. (2018) conducted a study based on the premise that the use of prescription benzodiazepines
may be associated with an increased risk of death from overdose in patients who use opioids.
Similarly, Park et al. (2015) led a case-cohort study using information extracted from medical
records at the VA for 2004–2009. Co-use of benzodiazepines was defined as the use of
benzodiazepines while taking other prescription opioids by a patient throughout the study, which
was considered inappropriate prescribing practice.
The U.S. Military Health System provides medical care to approximately 9.4 million
recipients annually (Dietrich et al., 2018). These patients also routinely suffer from acute low
back pain. Within this health system, patients can receive care and treatment from physicians or
physician extenders, including physician assistants and nurse practitioners. Due to the veterans’
unique training and practices, such as intense simulations and combat readiness procedures,
physical and psychological pain were the primary contributor to the opioid crisis within Veteran
population (Dietrich et al., 2018). A study conducted by Dietrich et al, (2018), discovered
differences in the prescribing patterns among provider types. The study discovered that contracted
and civilian providers had higher odds of prescribing opioids than active-duty providers. Given
the significant contribution of inappropriate opioid prescribing to opioid-related harm, identifying
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these practices are essential to inform and improve opioid prescribing practices among health care
providers. Similarly, Declan et al. (2018) found relatively high rates of NMUPOs among veterans
prescribed opioids in the previous year (37%) and NMUPO occurrence over this study period
among those reporting no prior history of NMUPO (15%). The study results suggest that
providers who prescribe opioids should be aware of this risk when inappropriately prescribing
long-term opioids and assess for NMUPO even among those without evidence of abnormal
behavior.
Opioid Overdose
Prescription opioid medications are the most implicated substances in unintentional
overdoses. Lin et al. (2015) conducted a study that examined all adult patients nationally in the
VHA who died from unintentional prescription opioid overdose in fiscal years 2004–2007 and
used VHA services anytime within two years of their deaths (N = 1,813). For those whose last
treatment contact was in an outpatient setting (n = 1,457), findings from the study show that
primary care and mental health outpatient clinics provide an opportunity to identify and intercede
with patients at elevated risk for unintentional prescription opioid overdose (Lin et al., 2015).
Data related to veterans who overdose on opioid and those who die from opioid overdose can be
found in the VHA National Patient Care Database, and the National Death Index. The National
Death Index coded the non-synthetic and semisynthetic opioids that caused overdose, such as
codeine, morphine, oxycodone, hydrocodone, oxymorphone, hydromorphone, and synthetic
opioids such as methadone (Lin et al., 2015). Im et al. (2015) substantiated that patients receiving
opioid therapy are at higher risk of attempting suicide; however, conclusive research to guide
clinical practice for risk mitigation is missing. Unmanaged severe, chronic, and intermittent pain
conditions increase the risk of suicide attempts, a finding that may encourage providers to take
aggressive interventions to decrease pain in the at-risk population. Similarly, Boyle et al, (2018)
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states that “VA emergency department visits related to opioid use nearly tripled from 2004 to
2011. Patients with mental illness are more likely to be prescribed opioids and have higher rates
of overdose (p.276). Despite experiencing a non-fatal overdose, veterans continued to be
prescribed opioids without significant changes in the drug or dosage, some experienced repeated
overdose events, possibly due to poor communication and documentation of the non-fatal
overdose (Boyle, 2018).
The 65-year-old and above population has been significantly affected by the opioid crisis,
experiencing high rates of opioid prescribing, opioid-related overdose deaths, and opioid use
disorder (Jayawardhana et al., 2019). Many veterans suffer from comorbid physical and mental
illnesses (e.g., posttraumatic stress disorder, open and closed head trauma); these unique
experiences in combat, coupled with simultaneous use of prescription opioids and central nervous
system depressants, are relatively common. Twenty-seven percent of veterans prescribed opioids
were jointly prescribed benzodiazepines, causing a central nervous system suppression (Park et
al., 2015). When veterans use opioids and benzodiazepines together, there is an increased
likelihood of the veteran being seen in the emergency room and admitted for opioid overdose
(Sun et al., 2017). Dwyer et al. (2015) made similar findings; in their study, veterans receiving
opioid analgesic and benzodiazepine prescriptions had an increased risk of death from a drug
overdose in an excessive level of exposure. The participants represented a high-risk population;
between their emergency room visit and study interview, more than one fifth of the veterans
reported the combined use of these medications, implicated in nearly half of all veteran opioid
overdose deaths (Park et al., 2015).
Opioid Safety
The VHA designed the OSI to decrease opioid prescribing practices related to adverse
outcomes across VHA facilities nationwide (Lin et al., 2017). There was a decreasing trend in
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high-dose opioid prescribing with 55,722 patients receiving daily opioid dosages > 100
milliequivalent (MEQ) in October 2012, and in September 2014, there was a continued reduction
in these numbers high-dose opioid prescribing. The OSI was also associated with an additional
decrease, compared to pre-OSI trends, of 331 patients per month receiving opioids > 100 MEQ, a
decrease of 164 patients per month receiving opioids > 200 MEQ, and a decrease of 781 patients
per month receiving concurrent benzodiazepines.
Comparison of Literature
The significant areas of focus to explain the reduction in numbers include the creation and
use of the OSI Dashboard, which aggregates EHR data to audit immediate opioid-related
prescribing and identify a clinical champion at every medical center to implement and enforce the
tool’s use to promote safer prescribing (Lin et al., 2017). The OSI aims to reduce overprescribing
of opioid analgesics for pain management and promote the safe and effective use of opioid
treatment when clinically indicated. Comprehensive OSI strategies include education of providers
and expanded access to non-pharmacological treatment options, particularly behavioral and
complementary integrative health modalities. The OSI Dashboard makes the totality of opioid use
visible within VHA and provides feedback to stakeholders at VA facilities regarding key
parameters of opioid prescribing, as previously discussed (Lin et al., 2017).
Similarly, opioid prescribing trends followed a downward trend in the VHA and non-VHA
settings that saw veterans, peaking around 2012 and declining since. However, changes in longterm opioid prescribing practices were responsible for most of the decline in the VHA. Recent
VA opioid initiatives may be preventing patients from initiating long-term use (Hadlandsmyth et
al., 2018).
The PDMP is another tool to aid in implementing safe practices at the VA. Hospitals
located in areas with high rates of opioid prescribing are less likely to have PDMPs integrated
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into the EHR, limiting the impact of PDMPs in these vital areas of the country (Dowell et al.,
2016). A CDC evaluation found that most fatal overdoses occurred when patients received
opioids from multiple prescribers or received high total daily opioid dosages (Dowell et al.,
2016). Similarly, the VA OIG (2017) found that VA and non-VA providers did not always access
the state PDMP databases and use the information to coordinate and manage their patients’ care.
The use of PDMP databases is essential to the VA’s ongoing efforts to combat veteran opioid
abuse, overmedication, and death; the OIG conducted their audit to determine whether VA
clinicians effectively used state operated PDMPs. Database information is used to manage and
coordinate the care of patients prescribed opioids but findings revealed that the PDMP was not
always used (VA OIG, 2017).
Implication for Practice
First, the improvement of opioid safety for high-risk veterans should include a VHA
Opioid Therapy Risk Report. This report can determine whether a provider has prescribed opioids
to a veteran who is receiving long-term opioid therapy. The OTRR is available to providers
through the veteran’s EHR. This tool provides information on any opioid and concurrent
benzodiazepine prescriptions a veteran is receiving, the veteran’s current and prior health
conditions, recent and upcoming appointments, and whether any opioid risk mitigation strategies
have been employed, such as urine drug screening or PDMP query.
Second, further research is needed on the PDMP regarding why some providers chose not
to use this tool. The PDMP can be used when the patient’s medication history is not otherwise
available, such as with a new patient or a visiting patient from another provider. In the case of
missing medication history, regardless of the PDMP results, the provider is must contact the
patient’s primary care provider to obtain more detailed patient information. The PDMP allows the
provider and pharmacist to become aware of other prescribers involved in the patient’s care and
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become informed about the patient’s information and history. The results from a PDMP search
should then be used to clarify to the prescriber and pharmacist which opioids and other Scheduled
II-V medications have been dispensed to the patient. The list of medications should be confirmed
with the patient. The importance of providers’ use of the PDMP cannot be stressed enough to
prevent a patient from obtaining prescription opioids from multiple providers, potentially leading
to overdose or death.
Third, the VHA recognizes the clinical challenges to successfully managing pain and
prescribing safely for veterans while implementing the OSI Directive. The National Pain
Management Program Office convened a national task force comprised of multidisciplinary pain
experts to create the OSI Toolkit (evidence-based to the extent possible) to guide the field. The
resulting Toolkit contains documents and presentations that aid clinical decisions about starting,
continuing, or tapering opioid therapy and other challenges related to safe opioid prescribing.
Providers who comply with the OSI will have positive outcomes; those who do not competently
use the OSI run the risk of harming the patients by facilitating overdosing or not recognizing the
individuals at risk for opioid overdose deaths. Therefore, the OSI, including the PDMP, must be
thoroughly implemented by all providers treating veterans.
Dissemination Plan
Participating in research introduces the prospect of improving individuals’ health in daily
practice and affecting on patients’ lives across the country and globally when the research is
translated into clinical practice. However, practice change cannot occur if researchers, clinicians,
and providers are unaware of the research that has been performed. It should be highlighted that
researchers have a moral duty to disseminate their research findings (Edwards, 2015). Nurses who
provide direct care to patients fall short of engaging in research mainly because there is no
institutional support to facilitate and encourage nurse research participation or formalize nurses’
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continuous professional development. Professional development could change nurses’ attitudes
toward research and contribute to improving health care, as it would increase the nurse’s role as
an agent for evidence-based clinical practice (Isaac et al., 2018).
Various approaches are available for disseminating research findings, but the most
common are publications in quality improvement journals and presentations at professional
meetings. Presentations may take the form of either oral or poster presentations. Presenting
clinical practice or research at a professional meeting offers the opportunity to disseminate
research findings quickly to those who have the potential to translate the evidence into practice.
Conferences are often attended by leaders in the field, who are more likely to be initiators of
translating research into practice. The poster format offers the additional advantage of simplifying
the personal interaction between researcher and practitioner. Researchers can explain their project
in detail and receive feedback that may be helpful for additional studies (Edwards, 2015).
Conclusion
Barriers to the implementation and enforcement of the PDMP identified in the literature
included which prescribers (Physicians or NPs), which patients and prescriptions they prescribed.
For instance, exemptions in Massachusetts’s opioid prescribing cap law excludes patients with
chronic noncancer pain and other debilitating conditions from the seven-day prescription limit.
This confused prescribers, impeding their ability to quickly determine whether prescribing an
opioid for a given patient was legal. Insufficient information technology infrastructure,
particularly about the utilization of the PDMP, was another barrier described in the study by
(Stone et al., 2020); PDMP data were also essential for prescription auditing, described as an
enforcement strategy. Lack of integration of the PDMP with EHRs or delegate access capabilities
was flagged as a barrier to implementation, mainly due to its disruption to clinicians’ workflow
(Stone et al., 2020).

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

37

Over the last several years, Congress has implemented purchased care programs to enable
veterans to access medical care in a health care facility near their home when feasible. The
Mission Act addresses VA care and non-VA health care issues, veterans’ homes, access to walkin VA care, prescription drug procedures, and much more. This VA improvement affects a wide
range of areas, and the official name of this law says a lot about its focus. Informally known as
the VA Mission Act, the legislation’s formal name is the VA Maintaining Systems and
Strengthening Integrated Outside Networks Act. The VA has worked in partnership with medical
professionals and support staff in the community who are not VA employees and do not work in
VA facilities to provide timely, accessible, high-quality care. What has commonly been referred
to as “community care” is now referred to as “non-VA care,” “fee basis care,” or “purchased
care.” Congress has authorized the VA to use various community care programs to provide care
to veterans when a VA facility cannot provide clinical services (U.S. Department of Veterans
Affairs, 2017).
All VA providers must review and reconcile, with their patients, the list of medications in
the patient’s current EHR with the medications the patient is taking. The OIG found that 41%, or
58 of 141 VA medical facilities reported that out-of-state licensed providers had no access to
PDMPs. Of the 58 facilities that employed staff who were unable to access PDMPs, 71% (41 of
58) reported having alternative processes allowing a review of PDMP data, such as having a
licensed state pharmacist or other appropriate provider review the PDMP and document the
findings in the EHR. Reconciling medications does not require the provider to use PDMP;
however, it is a safety initiative that tells how many prescriptions of opioids the veteran has
received (VA OIG, 2018).
The OSI initiative was designed to mitigate unsafe and ineffective opioid prescribing
practices of non-VA providers who treat veterans. This integrative review established that the OSI
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initiative has been effective in improving the opioid prescribing practices of providers because of
the real-time data seen on the OSI dashboard. However, there are still challenges, as all providers
are not using the PDMP, and some do not follow the steps of the OSI.
Steps of the risk-mitigating strategies of the OSI upon initiation of acute and long-term
opioid therapy include beginning with an informed consent conversation covering the risks and
benefits of opioid therapy and alternative therapies. The safety strategies and their frequency
should be equal with risk factors and include:
•

Ongoing, random urine drug testing (including positive or negative results)

•

Checking state PDMPs

•

Monitoring for overdose potential and suicidality

•

Providing overdose education

•

Prescribing naloxone rescue and accompanying education (U.S. Department of Veterans
Affairs, 2017)
State PDMP database inquiries for the discovery of multi-sourcing of controlled

substances are used throughout the country. Data comparing states with implemented state
PDMPs to states without one showed 1.55 fewer deaths per 100,000 people in states with an
implemented PDMP. The CDC currently recommends at least quarterly checks of the state
database system (Dowell et al., 2016).
Not only is the OSI intended to mitigate the unsafe opioid prescribing practices, but in the
process, the OSI toolkit improves communication between clinicians and patients. With
communication the risks and benefits of opioid therapy for acute and chronic pain, improve the
safety and effectiveness of pain treatment, and reduce the risks associated with long-term opioid
therapy, including opioid use disorder, overdose, and death should be discussed. The VHA is
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dedicated to assessing guidelines to identify the effects on clinicians and patient outcomes
intended and unintended. The VHA will revisit the OSI guidelines to monitor gaps that must be
sufficiently addressed to warrant an update of the guideline and study recommendations for future
updates when necessary.

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

40

References
Agency for Healthcare Research and Quality. (2018). Care coordination.
https://www.ahrq.gov/ncepcr/care/coordination.html
Bohnert, A. S., Ilgen, M. A., Galea, S., McCarthy, J. F., & Blow, F. C. (2011). Accidental
poisoning mortality among patients in the Department of Veterans Affairs Health System.
Medical Care, 49(4), 393–396. https://doi.org/10.1097/MLR.0b013e318202aa27
Boudreau, D., Von Korff, M., Rutter, C. M., Saunders, K., Ray, G. T., Sullivan, M. D., Campbell,
C. I., Merrill, J. O., Silverberg, M. J., Banta-Green, C., & Weisner, C. (2009). Trends in
long-term opioid therapy for chronic noncancer pain. Pharmacoepidemiology and Drug
Safety, 18(12), 1166–1175. https://doi.org/10.1002/pds.1833
Boyle, J., Clement, C., Atherton, A., Stock, C. (2017). A retrospective chart review of opioid represcribing following a non-fatal overdose at a Veterans Affairs hospital. Mental Health
Clinic, 7(6), 276–281. https://doi.org/10.9740/MHC.2017.11.276 PMCID: PMC6007726.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in
Psychology, 3(2), 77–101. https://doi.org/10.1191/1478088706qp063oa
Brown, S. J. (1999). Knowledge for health care practice: A guide to using research evidence. W.
B. Saunders
Center for Disease Control. (2020). Wide-ranging online data for epidemiologic research
(WONDER). Atlanta, GA: CDC, National Center for Health Statistics.
https:www.cdc.gov/drugoverdose/data/prescribing
Daubresse, M., Chang, H. Y., Yu, Y., Viswanathan, S., Shah, N. D., Stafford, R. S., Kruszewski,
S. P., & Alexander, G. C. (2013). Ambulatory diagnosis and treatment of nonmalignant
pain in the United States, 2000-2010. Medical Care, 51(10), 870–878.
https://doi.org/10.1097/MLR.0b013e3182a95d86

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

41

Declan, B. W., Gordone, A., Crystal, S., Kernsad, R. D., Gaithera, J. R., Gordon, K. S., Justice, A.
C., Fiellin, D. A., & Edelman, J. E. (2018) Duration of opioid prescriptions incident
nonmedical use of prescription opioids. Drug and Alcohol Dependence, 191(1), 348–354.
Derclaye, E. (2002). What is database: critical analysis of the definition of database in the
European database directive and suggestions for an international definition. Journal of
World Intellectual Property, 5(6), 981-1012.
Dietrich, E. J., Leroux, T., Santiago, C. F., Helgeson, M. D., Richard, P., & Koehlmoos, T. P.
(2018). Assessing practice pattern differences in the treatment of acute low back pain in
the united states military health system. BMC Health Services Research, 18(1), Article
720. https://doi.org/10.1186/s12913-018-3525-8
Dowell, D., Haegerich, T. M., & Chou, R. (2016). CDC guideline for prescribing opioids for
chronic pain—United States, 2016. JAMA, 315(15), 1624–1645.
https://doi.org/10.1001/jama.2016.1464
Dwyer, K., Walley, A. Y., Langlois, B. K., Mitchell, P. M., Nelson, K. P., Cromwell, J., &
Bernstein, E. (2015). Opioid education and nasal naloxone rescue kits in the emergency
department. The Western Journal of Emergency Medicine, 16(3), 381–384.
https://doi.org/10.5811/westjem.2015.2.24909
Edwards, D. (2015). Dissemination of research results: On the path to practice change. The
Canadian Journal of Hospital Pharmacy, 68(6), 465–469.
https://doi.org/10.4212/cjhp.v68i6.1503
Gagliardi, U. (1980). Software: What is it. APLA Quarterly Journal, 8(3), 233-239.
Garrard, J. (2017). Health sciences literature review made easy: The matrix method. Jones and
Bartlett Learning.

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

42

Goldman, K. D., & Schmalz, K. J. (2004). The matrix method of literature reviews. Health
Promotion Practice, 5(1), 5–7. https://doi.org/10.1177/1524839903258885
Guo, Q., & Jacelon, C. S. (2014). An integrative review of dignity in end-of-life care. Palliative
Medicine, 28(7), 931–940. https://doi.org/10.1177/0269216314528399
Hadlandsmyth, K., Mosher, H., M., Vander Weg, M. W., & Lund, B. C. (2018). Decline in
prescription opioids attributable to decreases in long-term use: A retrospective study in the
Veterans Health Administration 2010–2016. Journal of General Internal Medicine, 33,
818–824. https://doi.org/10.1007/s11606-017-4283-8
Homewood, F. (2000). Lx. Computer Architecture News, 28(2), 203–213.
https://doi.org/10.1145/342001.339682
Im, J. J., Shachter, R. D., Oliva, E. M., Henderson, P. T., Paik, M. C., & Trafton, J. A. (2015).
Association of care practices with suicide attempts in US veterans prescribed opioid
medications for chronic pain management. Journal of General Internal Medicine, 30(7),
979–991. https://doi.org/10.1007/s11606-015-3220-y
Isaac, N., Catherine, A., Gunilla, P., & Cumber, S. N. (2018). Barriers for nurses’ participation in
and utilisation of clinical research in three hospitals within the Kumasi Metropolis, Ghana.
The Pan African Medical Journal, 30(24).
https://doi.org/10.11604/pamj.2018.30.24.15230
Jayawardhana, J., Abraham, A. J., & Perri, M. (2019). Deaths among opioid users: Impact of
potential inappropriate prescribing practices. The American Journal of Managed Care,
25(4), e98–e103.
Kim, B., Nolan, S., Beaulieu, T., Shalansky, S., & Ti, L. (2019). Inappropriate opioid prescribing
practices: A narrative review. AJHP: Official Journal of the American Society of HealthSystem Pharmacists, 76(16), 1231–1237. https://doi.org/10.1093/ajhp/zxz092

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

43

Klemme Eliceiri, R. (2014). Zotero in faith community: Encouraging religious literacy through
the use of an online library. Advances in the Study of Information and Religion, 4(1), 6.
Lin, L., Bohnert, A. B., Ilgen, M. A., Pfeiffer, P. N., Ganoczy, D., & Blow, F. C. (2015).
Outpatient provider contact prior to unintentional opioid overdose among VHA service
users. Psychiatric Services, 66(11), 1149–1154.
https://doi.org/10.1176/appi.ps.201400194
Lin, L. A., Bohnert, A. S. B., Kerns, R. D., Clay, M. A., Ganoczy, D., & Ilgen, M. A. (2017).
Impact of the opioid safety initiative on opioid-related prescribing in veterans. Pain,
158(5), 833–839. https://doi.org/10.1097/j.pain.0000000000000837
Mathews, R. (2004). Developing a matrix approach to categorize the social and environmental
accounting research literature. Qualitative Research in Accounting & Management, 1(1),
30–45.
Melnyk B. M. (2016). Level of Evidence Plus Critical Appraisal of Its Quality Yields Confidence
to Implement Evidence-Based Practice Changes. Worldviews on evidence-based nursing,
13(5), 337–339. https://doi.org/10.1111/wvn.12181
Melnyk, B., Fineout-Overholt, E., Stillwell, S. B., & Williamson, K. M. (2010). Evidence-based
practice: Step by step: The seven steps of evidence-based practice. American Journal of
Nursing, 110(1), 51–53. https://doi.org/10.1097/01.naj.0000366056.06605.d2
Miles, M. B., & Huberman, A. M. (1994). Qualitative data analysis: An expanded sourcebook
(2nd ed.). SAGE Publications.
Moher, D., Liberati, A., Tetzlaf, J., Altman, D., F., The PRISMA Group. (2009). Preferred
reporting items for systematic reviews and meta-analyses: The PRISMA statement. PLos
Med, 6(7), Article1000097.

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

44

Moyo, P., Simoni‐Wastila, L., Griffin, B. A., Onukwugha, E., Harrington, D., Alexander, G. C.,
& Palumbo, F. (2017) Impact of prescription drug monitoring programs (PDMPs) on
opioid utilization among Medicare beneficiaries in 10 US states. Addiction, 112(10),
1784– 1796. https://doi.org/10.1111/add.13860

Page, M.J., Moher, D. (2017). Evaluations of the uptake and impact of the Preferred Reporting
Items for Systematic reviews and Meta-Analyses (PRISMA) Statement and extensions: a
scoping review. Systematic Review 6) (263). https://doi.org/10.1186/s13643-017-0663-8
Park, T. W., Saitz, R., Ganoczy, D., Ilgen, M. A., & Bohnert, A. B. (2015). Benzodiazepine
prescribing patterns and deaths from drug overdose among us veterans receiving opioid
analgesics: Case-cohort study. BMJ, 350, h2698–h2698.
https://doi.org/10.1136/bmj.h2698.
Pezalla, E. J., Rosen, D. J., Erensen, G., Haddox, J. D., & Mayne, T. J. (2017). Secular trends in
opioid prescribing in the USA. Journal of Pain Research, 10, 383–387.
Polit, D., & Beck, C. (2014). Essentials of nursing research: Appraising evidence for nursing
practice (8th ed.). Wolters Kluwer Health/Lippincott Williams & Wilkins.
Rose, A. J., Bernson, D., Chui, K., Land, T., Walley, A. Y., LaRochelle, M. R., Stein, B. D., &
Stopka, T. J. (2018). Potentially inappropriate opioid prescribing, overdose, and mortality
in Massachusetts, 2011–2015. Journal of General Internal Medicine, 33(9), 1512–1519.
https://doi.org/10.1007/s11606-018-4532-5
Rudd, R. A., Aleshire, N., Zibbell, J. E., & Gladden, R. M. (2016). Increases in drug and opioid
overdose deaths—the United States, 2000–2014. Morbidity Mortal Weekly Report, 64(50),
1378–1382.

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

45

Schiller, E. Y., Goyal, A., Mechanic O. J. (2021). Opioid overdose. StatPearls.
https://www.ncbi.nlm.nih.gov/books/NBK470415/
Singh, J. (2013). Critical appraisal skills program. Journal of Pharmacology &
Pharmacotherapeutics, 4(1), 76–77.
Snyder, H. (2019). Literature review as a research methodology: An overview and guidelines.
Journal of Business Research. 104(2019), 333-339.
Stone, E. M., Rutkow, L., Bicket, M. C., Barry, C. L., Alexander, G. C., & McGinty, E. E. (2020).
Implementation and enforcement of state opioid prescribing laws. Drug and Alcohol
Dependence, 213, Article 108107. https://doi.org/10.1016/j.drugalcdep.2020.108107
Sun, E. C., Dixit, A., Humphreys, K., Darnall, B. D., Baker, L. C., & Mackey, S. (2017).
Association between concurrent use of prescription opioids and benzodiazepines and
overdose: retrospective analysis. BMJ, 356, 760–767. https://doi.org/10.1136/bmj.j760
Toronto, C. E., & Remington, R. (2020). A step-by-step guide to conducting an integrative
review. Springer.
Trinoskey, J., Brahmi F., A., & Gall, C. (2009). Zotero: A product review. Journal of Electronic
Resources in Medical Libraries, 6(3), 224–229.
https://doi.org/10.1080/15424060903167229
U.S. Department of Veterans Affairs. (2017). US VA/DOD clinical practice guideline for opioid
therapy for chronic pain. https://www.healthquality.va.gov/guidelines/Pain
/cot//VADoDOTCPG022717.pdf
VA Office of Inspector General. (2017). Opioid prescribing to high-risk veterans receiving VA
purchased care (Report No. 17-01846-316). U.S. Department of Veterans Affairs.
https://www.va.gov/oig/pubs/VAOIG-17-01846-316.pdf

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

46

VA Office of Inspector General. (2018). Review of pain management services in Veterans Health
Administration facilities (Report No. 16-00538-282). U.S. Department of Veterans
Affairs. https://www.va.gov/oig/pubs/VAOIG-16-00538-282.pdf
Vivolo-Kantor A. M., Seth, P., Gladden, R. M., Mattson, C. L., Baldwin, G. T., & Kite-Powell,
A. (2018). Vital signs: Trends in emergency department visits for suspected opioid
overdoses—United States, July 2016–September 2017. Morbidity Mortality Weekly
Report, 67(9), 279–285.
Whittemore, R. & Knafl, K. (2005). Methodological issues in nursing research: The integrative
review—updated methodology. Journal of Advanced Nursing, 52(5), 546–553.

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH

47

Appendix A
Evidence Table
Article

Beaudoin, F. L.,
Banerjee, G. N., & Mello,
M. J. (2016). State-level
and system-level opioid
prescribing policies: The
impact on provider
practices and overdose
deaths, a systematic
review. Journal of Opioid
Management, 12(2), 109–
118.
https://doi.org/10.5055/jo
m.2016.0322

Background

Study Purpose

Design

In response to
persistent public
health concerns
regarding
prescription
opioids, many
states and
healthcare systems
have implemented
legislation and
policies intended to
regulate or guide
opioid prescribing.
The overall impact
of these policies is
still uncertain

This systematic
review
examined the
existing
evidence of
provider-level
and patient-level
outcomes
reimplementatio
n and
postimplementat
ion of policies
and legislation
constructed to
impact provider
prescribing
practices around
opioid
analgesics.

Systematic
review

Results

These policies may
impact the number of
overdoses, but there is
no clear evidence to
suggest that it reduces
opioid misuse.

Level of
Evidence
Level II

Source

Primary

Database
or library
source
PubMed

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH
Article

Background

Study Purpose

Design

Boyle, J., Clement, C.,
Atherton, A., Stock, C.
(2017). A retrospective
chart review of opioid represcribing following a
non-fatal overdose at a
Veterans Affairs hospital.
Mental Health Clinic,
7(6), 276–281.
https://doi.org/10.9740/M
HC.2017.11.276 PMCID:
PMC6007726.

Patients with
mental illness are
more likely to be
prescribed opioids
and have higher
rates of overdose.
This retrospective
chart review sought
to determine if
opioid represcribing
occurred after
patientswere treated
for a non-fatal
opioid overdose
(NFO) at a
Veterans Affairs
hospital

To determine if
Retrospecti
opioid reve review
prescribing
occurred after
the patients were
treated for a
non-fatal opioid
overdose (NFO)
at a Veterans
Affairs hospital.

Carlson, K. F., Gilbert, T.
A., Morasco, B. J.,
Wright, D., Otterloo, J.
V., Herrndorf, A., &
Cook, L. J. (2018).
Linkage of VA and state
prescription drug
monitoring program data
to examine concurrent
opioid and sedativehypnotic prescriptions
among veterans. Health

The State
prescription
Monitoring
Program is an
excellent way for
providers to
prevent Veterans
from receiving
multiple opioid
prescriptions.
However, having
this tool is not

To examine the
Multivariat
proportion of the e trend
Veteran
analysis
population who
receive VA and
non‐VA
prescriptions for
opioids and
sedative‐
hypnotic
medications
among post‐9/11

48
Results

Level of
Evidence

Source

Fifty-six veterans met
the inclusion criteria. A
new opioid prescription
was issued to 82% of
Patients within three
months following the
index NFO date. The
average daily morphine
equivalent dose
prescribed before (122
mg) and after (120 mg)
NFO did not differ. A
subsequent opioid
overdose event
occurred in 25% of
patients, and there was
one fatal event. Only
one patient had
medication overdose on
the problem list of their
EMR.
Of the 19,959 post 9/11 Veterans, Results
revealed that 5,882
Veterans who filled
opioid or sedative‐
hypnotic prescriptions
at VA pharmacies,
1,036 (17.6 percent),
filled concurrent
prescriptions non‐VA
pharmacies. 4.6 percent
of Veterans received

Level III

Primary

Database
or library
source
PubMed

Level I

Primary

PubMed

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH
Article

Background

Study Purpose

Services Research,
53(Suppl. 3), 5285–5308.
https://doi.org/10.1111/14
75-6773.13025

being used as it
should be by
providers or
providers who do
not have the
technology to
access the program.

veterans in
Oregon at the
same time.

Chui, P. W., Bastian, L.
A., DeRycke, E., Brandt,
C. A., Becker, W. C., &
Goulet, J. L. (2018). Dual
use of the Department of
Veterans Affairs and
Medicare benefits on
high-risk opioid
prescriptions in veterans
aged 65 years and older:
Insights from the VA
musculoskeletal disorders
cohort. Health Services
Research, 53, 5402–
5418.
https://doi.org/10.1111/14
75-6773.13060

Among Veterans
aged 65 years or
older, dual use of
both VHA and
Medicare was
associated with
higher odds of
long‐term opioid
therapy. Our
findings suggest
there may be a
benefit to
combining VHA
and non‐VHA
electronic health
record data to
minimize exposure
to high‐risk opioid
prescribing

To examine the
association of
Veterans Health
Administration
(VHA) and
Medicare
benefits with
high‐risk opioid
prescriptions
among Veterans
aged 65 years
and older with a
musculoskeletal
disorder
diagnosis
(MSD)

Design

Retrospecti
ve review

49
Results

concurrent VA and
non‐VA opioids,
benzodiazepines. There
was a lack of
generalization of trends
observed in Oregon to
other states. Oregon
had among the highest
rates of nonmedical use
of prescription
analgesics in the
country
The study revealed that
when patients use both
the VA and Medicare
benefits, they are more
likely to be prescribed
opioid therapy. Only
Veterans who used the
VA were included in
this study. The study
data are based on VA
and Medicare data
subject to clerical and
coding errors.

Level of
Evidence

Level III

Source

Primary

Database
or library
source

PubMed

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH
Article

50

Background

Study Purpose

Design

Results

Level of
Evidence

Source

Declan, B. W., Gordone,
A., Crystal, S., Kernsad,
R. D., Gaithera, J. R.,
Gordon, K. S., Justice, A.
C., Fiellin, D. A., &
Edelman, J. E. (2018)
Duration of opioid
prescriptions incident
nonmedical use of
prescription opioids.
Drug and Alcohol
Dependence, 191(1),
348–354.

Nonmedical use of
prescription opioids
has limited studies
related to the
Veteran clinical
population.
Providers need to
monitor their
patients on Longterm opioids as this
is a risk factor for
overdose and death.

Prospective
cohort
study

Prescribing naloxone
rescue kits should be a
collaborative effort
between prescribers
and pharmacists. Both
must recognize and
mitigate overdose risk.

Level IV

Primary

Dietrich, E. J., Leroux,
T., Santiago, C. F.,
Helgeson, M. D.,
Richard, P., &
Koehlmoos, T. P. (2018).
Assessing practice pattern
differences in the
treatment of acute low
back pain in the united
states military health
system. BMC Health
Services Research, 18(1),
Article 720.
https://doi.org/10.1186/s1
2913-018-3525-8

Acute low back
pain is one of the
most common
reasons individuals
seek medical care
in the United States
Military Health
System. It provides
medical care to
approximately 9.4
million
beneficiaries
annually.

In this narrative
review of
overdose
prevention and
the role of
prescribers and
pharmacists in
distributing
naloxone
we address these
priority areas
and present a
clinical scenario
within the
review
Evaluate
variation in care
delivery,
adherence to
clinical
guidelines, and
differences
within the
Military Health
System among a
complex mix of
provider types.

Database
or library
source
PubMed

Retrospecti
ve, crosssectional
quantitative
analysis

Like NPs, there was a
significant decrease, by
a factor of .58 for
ordering CTs and a
marginal decrease for
prescribing opiates and
ordering MRIs. The
absence of more
detailed provider
characteristics includes
years of experience,
academic institution,
medical residency
training, and additional
education or
certifications. This
information would

Level I

Primary

PubMed

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH
Article

Driscoll, M. A., Knobf,
M. T., Higgins, D. M.,
Heapy, A., Lee, A., &
Haskell, S. (2018).
Patient experiences
navigating chronic pain
management in an
integrated health care
system: A qualitative
investigation of women
and men. Pain Medicine,
19(Suppl. 1), S19–S29.
https://doi.org/10.1093/p
m/pny139

Dwyer, K., Walley, A.
Y., Langlois, B. K.,
Mitchell, P. M., Nelson,
K. P., Cromwell, J., &
Bernstein, E. (2015).
Opioid education and
nasal naloxone rescue
kits in the emergency
department. The Western
Journal of Emergency
Medicine, 16(3), 381–
384.

Background

Rates of pain
among veterans are
as high as 60%;
rates approach 80%
in women seeking
Department of
Veterans Affairs
(VA) care. Prior
studies examined
experiences
managing pain in
community
samples, with
gender disparities
observed, as the
country’s most
extensive national
integrated health
care system.
Program
participants were
surveyed by
telephone after
their ED visit about
their substance use,
overdose risk
knowledge, history
of witnessed and
personal overdoses,
and actions in a
witnessed

Study Purpose

A purposive
sample of
chronic pain
patients was
recruited to
qualitatively
describe
perceptions of
managing pain
in an integrated
health care
system (VA)
and to explore
gender
differences

To determine
the feasibility of
an ED-based
overdose
prevention
program that
included nasal
naloxone kits.

Design

51
Results

support the human
capital hypothesis.
Comparativ The focus groups of
e approach men revealed the theme
with
that reflected pain as a
sequential
constant struggle,
analysis
To medicate or not to
medicate is reflected by
women 1. The data is
old; the policy changes
may have occurred that
address many of the
concerns.
2. There may be
variation in the various
pain treatment and pain
management
approaches

Cohort
study

There were no
statistically significant
differences between
OEN and OE-only
groups in opioid use,
overdose, or response
to a witnessed
overdose.

Level of
Evidence

Source

Database
or library
source

Level V

Primary

PubMed

Level II

Primary

PubMed

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH
Article

Background

https://doi.org/10.5811/w
estjem.2015.2.24909
Gibson, C., Grasso, J., Li,
Y., Purcell, N., Tighe, J.,
Zamora, K., Nicosia, F.,
Seal, K. (2020). An
integrated pain team
model: Impact on painrelated outcomes and
opioid misuse in patients
with chronic pain. Pain
Medicine, 21(9), 1977–
1984.
https://doi.org/10.1093/p
m/pnaa003

overdose, including
naloxone.
Integrated pain
team (IPT) care
models are being
implemented in
Veterans Health
Administration
(VA) and other
health care systems
to address chronic
pain and reduce
risks related to
long-term opioid
therapy, with little
evaluation of
effectiveness to
date.

Hadlandsmyth, K.,
Mosher, H., M., Vander
Weg, M. W., & Lund, B.
C. (2018). Decline in
prescription opioids
attributable to decreases
in long-term use: A
retrospective study in the
Veterans Health
Administration 2010–
2016. Journal of General

Improved
understanding of
temporal trends in
short- and longterm opioid
prescribing may
inform efforts to
curb the opioid
epidemic.

52

Study Purpose

Design

Results

Level of
Evidence

Source

Database
or library
source

To determine if
IPT improves
self-reported
pain-related
outcomes and
opioid misuse.

Singlegroup
quality
improveme
nt study

Level IV

Primary

PubMed

To characterize
the prevalence
of short- and
long-term opioid
prescribing in
the Veterans
Health
Administration
(VHA) from
2010 to 2016.

Observatio
nal cohort
study using
VHA
databases

After an average (SD)
of 14.3 (9) weeks
engaged in IPT,
patients reported
improvement in pain
interference (mean
[SD] = 46.0 [15.9] vs
40.5 [16.2], P < 0.001),
pain catastrophizing
(mean [SD] = 22.9
[13.0] vs 19.3 [14.1], P
= 0.01), treatment
satisfaction (i.e., “very
satisfied” = 13.1% at
baseline vs 25.3% at
follow-up, P = 0.01),
and reduced opioid
misuse (mean [SD] =
11.0 [7.5] vs 8.2 [6.1],
P = 0.01).
The prevalence of
opioid prescribing was
20.8% in 2010, peaked
at 21.2% in 2012, and
declined annually to
16.1% in 2016.
Between 2010 and
2016, reductions in
long-term opioid
prescribing accounted
for 83% of the overall

Level III

Primary

PubMed

MITIGATING THE RISK OF OPIOID OVERDOSE AND DEATH
Article

Background

Study Purpose

Design

Internal Medicine, 33,
818–824.
https://doi.org/10.1007/s1
1606-017-4283-8
Im, J. J., Shachter, R. D.,
Oliva, E. M., Henderson,
P. T., Paik, M. C., &
Trafton, J. A. (2015).
Association of care
practices with suicide
attempts in US veterans
prescribed opioid
medications for chronic
pain management.
Journal of General
Internal Medicine, 30(7),
979–991.
https://doi.org/10.1007/s1
1606-015-3220-y

Patients receiving
opioid therapy are
at elevated risk of
attempting suicide.
Guidelines
recommend
practices to
mitigate risk, but it
is not known
whether these are
effective.
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Kim, B., Nolan, S.,
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While prescription
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acute pain,
inappropriate
prescribing
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opioid-related
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overdose and
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to identify
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prescribing are
presented.
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unintentional
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Death from a drug
overdose is defined
as any intentional,
unintentional, or
indeterminate death
from poisoning
caused by any drug,
determined by
information on the
cause of death from
the National Death
Index.

To find the
association
between
benzodiazepine
prescribing
patterns and the
risk of death
from drug
overdose among
US veterans
receiving opioid
analgesics.

Casecohort
study.

n=112 069 of veterans
who received opioid
analgesics also received
benzodiazepines. About
half of the deaths from
drug overdose
(n=1185) occurred
when veterans have
concurrently prescribed
benzodiazepines and
opioids.

Level II
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(VA.) has
implemented robust
strategies to
monitor
prescription opioid
dispensing, but
these strategies
have not accounted
for opioids
prescribed by nonVA providers.
State-based
prescription drug
monitoring
programs (PDMPs)
are a potential tool
to identify VA
patients’ receipt of
opioids from nonVA prescribers.

To determine if
the Prescription
Drug
Monitoring
Programs
(PDMP) have
the potential to
effectively
alleviate
Veterans’ use of
opioids from
VA and non-VA
prescribers
which could
potentially cause
harm.

Qualitative
study

Even though the VA
has improved the safe
prescribing practices,
these efforts have not
addressed the increased
number of opioid
prescriptions received
by Veterans outside of
the VA, and providers
accept the PDMPs as a
tool to monitor
Veterans’ receipt of
opioids from non-VA
sources despite
identifying multiple
barriers to optimal use.
VA data in some states
PDMP is still
unavailable.
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The advantages of
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VA outsourced
primary care. This
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more on providing
specialized care for
veterans in the VA
system while
coordinating with
CHCs for the
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outsourced, holistic
primary care. We
conclude that
failure to develop
an incremental,
cost-effective
alternative as
described herein
represents a
potential threat to
adequate future
support of our VA
hospital system
Potentially
inappropriate
prescribing (PIP)
may contribute to
opioid overdose.
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No design
features of the
Benefits of the
VA Mission Act
relevant to
outsourcing, the
challenges of the
Present Choice
Program, and
likely future
obstacles with
the new
legislation, and
the advantages
of expanding
Community
Healthcare
Centers VA
outsourced
primary care

There is a $55 Billion
commitment for five
years for the Mission
Act to address
shortcomings in the
VA.

To examine the
association
between PIP and
adverse events.

The PIP was
Level II
associated with a higher
adjusted hazard for allcause mortality, four of
six with non-fatal
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In response to the
role
overprescribing has
played in the US
opioid crisis, in the
past decade, states
have enacted four
main types of laws
to curb opioid
prescribing:
mandatory
prescription drug
monitoring
program (PDMP)
enrollment laws
requiring clinicians
to register with a
Prescription Drug
Monitoring
Program.

To determine
how research
can yield insight
into whether and
how
implementation
and enforcement
influence laws’
effects on
outcomes.

Interviews
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fatal overdose. Lacking
a documented pain
diagnosis was
associated with nonfatal overdose (adjusted
hazard ratio [AHR]
2.21, 95% confidence
interval [CI] 2.02-2.41),
as was high-dose
opioids (AHR 1.68,
95% CI 1.59-1.76).
Despite differing
Level VI
approaches, our
findings suggest similar
barriers to
implementation and
enforcement across
state opioid prescribing
laws. Strategies are
needed to ease the
implementation and
enforcement of laws
that apply only to
specific sub-sets of
providers, patients, or
prescriptions and
address access and data
utilization of the
PDMP.
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PRISMA Flow Diagram

Note. From “Preferred Reporting Items for Systematic Reviews and Meta-Analyses,” by D.
Moher, A. Liberati, J. Tetz Laf, & D. F. Altman, 2009, PLOS Medicine, 6(7), e000097.
https://doi.org/10.1371/journal.pmed.1000097
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